Genetico has received approval from Roszdravnadzor for the use of the non-invasive prenatal test Prenetics, which is designed to detect the risk of fetal genetic anomalies through the blood of a pregnant woman. Introduction of Prenetics into standard prenatal screening, according to published studies, can increase its effectiveness in detecting Down syndrome from 79% to 99.9%